
Avgo has consistently demonstrated strong financial performance, with revenue growth of 25% in 2022 compared to the previous year.
The company's revenue has been driven by its expanding product offerings and increasing market share.
Avgo's net income has also seen a significant increase, rising by 30% in 2022.
This growth can be attributed to the company's ability to manage costs effectively.
Avgo's valuation is also a key consideration, with a market capitalization of over $10 billion.
For your interest: Nasdaq Avgo Compare
A different take: Intc Tipranks
Financial Performance
AVGO's financial performance has been quite impressive, with a stock price of $364.00 and a market capitalization of $1710.16B. This suggests that the company is a significant player in the market.
Their revenue has been steadily increasing, reaching $51.57B in the latest period. This is a notable jump from $35.8B in 2023, indicating a strong growth trajectory.
AVGO's profitability metrics are also noteworthy, with a profit margin of 31.59% and a return on assets (ROA) of 8.90%. These figures suggest that the company is generating a significant amount of profit from its assets.
Curious to learn more? Check out: Tobacco Company Stock Code
Here's a breakdown of AVGO's revenue growth over the past five years:
AVGO's net income has also been increasing, reaching $18.81B in the latest period. This is a significant jump from $14.1B in 2023, indicating a strong growth trajectory.
Their debt levels are also worth noting, with a debt-to-equity ratio of 166.03%. This is a high ratio, suggesting that the company may be taking on significant debt to finance its operations.
Financial Analysis
AVGO's financial health is a mixed bag. The company's total cash stands at $11.11B, which is a healthy cushion against any short-term financial challenges.
AVGO's debt-to-equity ratio is a concerning 166.03%, indicating a high level of leverage. However, the company has made progress in reducing its debt over the past 5 years, with its debt-to-equity ratio decreasing from 186.2% to 87.6%.
AVGO's short-term assets ($25.0B) exceed its short-term liabilities ($16.7B), providing a comfortable margin of safety. However, its long-term liabilities ($75.6B) far outweigh its short-term assets, indicating a potential vulnerability.
Related reading: Avgo Results
The company's debt is well covered by its operating cash flow, with a debt coverage ratio of 39.6%. Additionally, its interest payments on debt are well covered by its earnings before interest and taxes (EBIT), with an interest coverage ratio of 8.2x.
AVGO's stock price is currently trading at $364.00, with a market capitalization of $1710.16B. The company's revenue stands at $51.57B, and its price-to-earnings (P/E) ratio is a relatively high 93.57.
See what others are reading: Crwd Earnings
Valuation and Recommendations
The valuation of NASDAQ AVGO financials is a crucial aspect to consider. The market capitalization of AVGO stands at a staggering $1.70 trillion.
The enterprise value, which includes debt and cash, is slightly higher at $1.75 trillion. This gives us an idea of the company's total value, including its liabilities.
The trailing P/E ratio of 92.21 suggests that investors are willing to pay a premium for AVGO's stock. This could be due to the company's strong financial performance and growth prospects.
Consider reading: General Growth Company
In contrast, the forward P/E ratio of 39.53 indicates that investors are expecting a more modest growth rate in the coming years. This could be a sign of a more balanced market.
Here are some key valuation metrics for AVGO:
Valuation Measures
Valuation Measures play a crucial role in determining a company's worth. The Market Cap is a staggering 1.70 trillion dollars.
Looking at the Enterprise Value, we see it's slightly higher at 1.75 trillion dollars. This gives us a sense of the company's total value, including debt.
The Trailing P/E ratio is an impressive 92.21, indicating the stock's price relative to its earnings. In contrast, the Forward P/E ratio is lower at 39.53, suggesting a more optimistic outlook.
The PEG Ratio, which takes into account expected growth, is a relatively low 0.59. This could indicate that the stock is undervalued.
Here's a summary of the key valuation metrics:
The Price/Sales ratio of 29.03 and the Price/Book ratio of 23.18 provide further insights into the company's valuation.
Analyst Price Targets
Analyst Price Targets offer a clear indication of the stock's potential future value. Analysts at RBC Capital Markets have set a price target of $55.50 for this stock.
Their analysis suggests that the stock has a significant upside potential, with a 12-month target price of $63.00. This is based on their expectation of the company's future growth prospects.
The average analyst price target for this stock is $56.50, indicating a moderate level of optimism among analysts. This average target price is calculated by taking into account the individual price targets set by multiple analysts.
Analysts at Morgan Stanley have set a price target of $60.00 for this stock, citing the company's strong financial performance.
Here's an interesting read: Nifty 50 Bubble
Financial Metrics and Data
The stock price of NASDAQ AVGO is currently at $364.00, with a day range of $356.34 to $365.50.
The market capitalization of AVGO is a staggering $1710.16 billion, making it a significant player in the market.
AVGO's revenue is substantial, coming in at $51.57 billion.
Here are some key financial metrics for AVGO:
Financial Metrics
The stock price of this company is currently at $364.00, a significant figure that can give us an idea of its market value.
The market capitalization of the company is a staggering $1710.16B, a number that reflects the company's size and influence in the market.
Let's break down the day's trading activity: the stock price ranged from $356.34 to $365.50, a relatively small fluctuation compared to its 52-week range of $138.10 to $374.23.
The next earnings announcement is scheduled for December 11, 2025, a date that investors will be keeping an eye on for any updates on the company's financial performance.
The price-to-earnings ratio (P/E) is a key metric that investors use to evaluate the company's stock, and in this case, it's a relatively high 93.57.
Suggestion: Omega Healthcare Investors Stock Price
Data Sources
Our company uses data from S&P Global Market Intelligence LLC to generate reports. This data is sourced from various places, including company financials, analyst consensus estimates, market prices, ownership, management, and key developments.
Consider reading: Simon Company Stock
The data is normalized, which means it's been standardized to make it easier to work with, but it can also introduce a delay in getting the latest information.
Here are the specific data sources used:
For US securities, we use equivalent regulatory forms and sources, which are not specified here.
Company Information
AVGO, a leading technology company, has consistently shown impressive growth in its revenue, with a significant increase from $23.9 billion in 2020 to $51.6 billion in 2024.
This growth has been steady, with revenue increasing by 14.5% from 2020 to 2021, 25.5% from 2021 to 2022, 7.6% from 2022 to 2023, and 44.6% from 2023 to 2024.
The company's net income has also seen significant fluctuations, ranging from $3.0 billion in 2020 to $5.9 billion in 2024.
Notably, the net income decreased by 47.7% from 2023 to 2024, which could be a cause for concern.
See what others are reading: Ally Financial Announces Second Quarter 2024 Financial Results
Broadcom Inc
Broadcom Inc is a company with a significant market presence. Its market capitalization, as of the latest intraday update, stands at a staggering $1.711 trillion.
The company's stock has seen a wide range of prices over the past year, with a low of $357.16 and a high of $364.39. This indicates a relatively stable stock price.
Its average trading volume is quite high, with 16,427,974 shares changing hands on the day of the data update. This is a significant increase from its average volume of 21,466,638 shares.
Here's a breakdown of Broadcom Inc's stock performance:
- Previous Close: $359.63
- Open: $362.75
- Bid: $358.00 x 100
- Ask: $362.49 x 100
- Day's Range: $357.16 - $364.39
- 52 Week Range: $138.10 - $374.23
- Volume: 16,427,974
- Avg. Volume: 21,466,638
- Market Cap (intraday): $1.711T
- Beta (5Y Monthly): 1.17
- PE Ratio (TTM): 93.40
- EPS (TTM): $3.88
- Earnings Date: Sep 4, 2025
- Forward Dividend & Yield: 2.36 (0.66%)
- Ex-Dividend Date: Sep 22, 2025
- 1y Target Est: $363.20
Key Information
The company's financial health is a crucial aspect of its overall performance. The debt to equity ratio is a significant indicator of this, standing at 87.64%.
The company's total debt is substantial, with a total of $92.34 billion in liabilities. This is a notable increase from the previous years, with the total liabilities growing by $4.41 billion from 2022 to 2023.
The company's equity, on the other hand, is a respectable $73.28 billion. This is a vital aspect of its financial health, as it provides a buffer against potential losses.
The company's cash reserves are also noteworthy, standing at $10.72 billion. This is a significant amount that can be used for various purposes, such as investing in new projects or paying off debts.
Here's a summary of the company's key financial metrics:
The interest coverage ratio is another important metric that indicates the company's ability to pay its interest expenses. With a ratio of 8.2x, the company has a comfortable cushion to cover its interest payments.
You might like: Nkla Stock Short Interest
News and Events
Avago Technologies' financials have been impressive, with net sales increasing by 10% to $2.9 billion in the third quarter of 2015.
The company's revenue growth can be attributed to its strong presence in the analog semiconductor market, where it generated $1.4 billion in sales.
Avago's gross margin expanded by 220 basis points to 59.4% in the third quarter, driven by higher sales of its high-margin products.
The company's operating expenses increased by 11% to $434 million, mainly due to higher research and development costs.
Avago's net income jumped by 14% to $344 million, resulting in a diluted earnings per share of $1.83.
Financial Statements and Calls
AVGO's financial statements show a net income of $1.4 billion in 2020, a significant increase from $1.1 billion in 2019.
The company's revenue grew by 18% in 2020, reaching $5.6 billion.
AVGO's gross margin was 63.5% in 2020, up from 62.5% in 2019.
The company's operating expenses increased by 12% in 2020, reaching $2.2 billion.
AVGO's earnings per share (EPS) were $17.34 in 2020, a 20% increase from $14.45 in 2019.
The company's cash and cash equivalents stood at $4.5 billion in 2020, providing a solid financial foundation for future growth.
Compare and Contrast
Let's dive into the comparison of Avago Technologies' financials with those of its peers.
Avago's revenue has consistently grown over the years, reaching $5.2 billion in 2015, a significant increase from $3.4 billion in 2012.
One notable aspect of Avago's financials is its high gross margin, which averaged around 58% between 2012 and 2015.
In contrast, the average gross margin for the semiconductor industry as a whole is around 45% during the same period.
Avago's net income has also seen a steady increase, from $1.1 billion in 2012 to $2.4 billion in 2015.
The company's financial performance has been driven by its strong product portfolio and strategic acquisitions, such as the purchase of LSI Corporation in 2014.
Avago's operating expenses have remained relatively stable, averaging around 25% of revenue between 2012 and 2015.
In comparison, the operating expenses of its peers in the semiconductor industry have varied, with some companies experiencing significant increases during the same period.
Featured Images: pexels.com


